Rovida Investment Management Ltd Purchases New Position in ASP Isotopes Inc. (NASDAQ:ASPI)

Rovida Investment Management Ltd purchased a new stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 218,972 shares of the company's stock, valued at approximately $990,000. ASP Isotopes accounts for 0.3% of Rovida Investment Management Ltd's holdings, making the stock its 18th largest position. Rovida Investment Management Ltd owned about 0.31% of ASP Isotopes at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. JPMorgan Chase & Co. boosted its holdings in ASP Isotopes by 31.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 22,196 shares of the company's stock valued at $62,000 after acquiring an additional 5,307 shares during the period. Hanson & Doremus Investment Management bought a new stake in ASP Isotopes in the fourth quarter valued at approximately $27,000. Avantax Advisory Services Inc. purchased a new stake in shares of ASP Isotopes during the fourth quarter valued at approximately $45,000. SVB Wealth LLC bought a new position in shares of ASP Isotopes in the fourth quarter worth approximately $49,000. Finally, Boston Financial Mangement LLC purchased a new position in shares of ASP Isotopes in the fourth quarter worth $50,000. Hedge funds and other institutional investors own 16.80% of the company's stock.

ASP Isotopes Trading Down 10.8 %

ASPI traded down $0.51 during trading on Friday, hitting $4.22. 1,116,622 shares of the stock traded hands, compared to its average volume of 2,222,159. The firm has a market capitalization of $301.34 million, a P/E ratio of -6.91 and a beta of 3.66. ASP Isotopes Inc. has a 12-month low of $1.86 and a 12-month high of $9.33. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54. The firm has a 50-day moving average of $5.04 and a 200 day moving average of $4.89.

Remove Ads

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.